Commercialized a highly effective skin cancer scanning device

Initial orders from its Brazilian distribution partner could result in $8M of hardware sales over the next 2 years

MedX Health Corporation Management

Mike Druhan

President, Dermatological Services and Products

Mike Druhan, who has championed SIAscopy™ within the Company for a number of years, has been appointed President, Dermatological Services and Products. The supporting teams in sales, training, production as well as software and hardware development for DSP will report to Mr. Druhan.

Dr. Trevor Champagne

Chair of Medical Advisory Board

Teledermatology is a subspecialty of dermatology that offers safe and effective virtual care—patient assessment and diagnosis—at a distance, eliminating the need for in-person appointments. With the world navigating through ongoing COVID-19 recovery measures, teledermatology's advancement has never been more critical to patient care and outcomes. Dr. Champagne will drive ongoing innovation with MedX's teledermatology offering, including the Company's leading-edge image capture technology (SIAscopy®) for moles, lesions and other skin conditions via its secure, cloud-based patient management system (DermSecure®), which transmits and stores patient data through the assessment process. MedX's SIAscopy® is the only technology that takes five images, including four spectrophotometric images 2 mm below the skin's surface.

In addition to his leadership appointment at MedX, Dr. Champagne is a dermatologist at the Women's College Hospital in Toronto, as well as an Assistant Professor (Clinician in Quality and Innovation, Division of Dermatology) at the University of Toronto's Temerty Faculty of Medicine, Canada's top-ranked medical school.

Rob von der Porten

Interim Executive Chair

Rob joined MedX in November, 2013 as Chief Executive Officer. He has an MBA from the Richard Ivey School of Business, and has nearly 40 years’ experience as an executive holding senior positions in a number of North American industrial, retail, manufacturing, marketing and technology companies.


Managing Director Light Therapy Products

Louie was Co-Clinical Director responsible for management, mergers and acquisitions for a group of several successful “G” Code and Schedule 5 OHIP physiotherapy and chiropractic clinics, introducing and utilizing laser therapy as a palliative modality. He was also a founder and held executive positions within several emerging growth Healthcare companies. Louie has a B. Sc. in Natural Health Sciences.


Chief Financial Officer

Jim has wide-reaching experience in senior financial executive roles in private and public companies in numerous sectors.
He has held CFO roles with several medical device and biopharmaceutical companies. Jim has for many years been part of a professional firm assisting companies ranging from emerging growth to entrepreneurial to large established companies, primarily with restructuring, growth initiatives and hands-on financial management. He is a Chartered Accountant and Certified Public Accountant.


Director of International Business Development

Larry is responsible for developing and managing an international network of MedX Product distributors for the MedX Siascopy Technology products (MoleMate) and the Therapeutic and Dental Laser Therapy Product line.
He also manages sales to some markets in the U.S. He has successfully developed and launched strategic sales and marketing plans for numerous medical devices, implementing them internationally, including Europe, Asia, Latin America, the Middle East and Australia. He is a graduate of the U.S. Naval Flight School, Pensacola, Florida, and served in combat in the United States Navy. He holds a BA in Marketing and Business from Iowa University.


Managing Director, Europe

Daniel’s specialty is high-tech commercialization strategy and implementation. Daniel is the former President and CEO of Environmental Waste International Inc. (a public company – TSX Venture: “EWS”)
Prior to EWS, Daniel was CEO of Renewable Energy Management Inc. where his principal roles were to define strategy, streamline operations, and raise capital. He successfully raised $3.2 million in seed funding from strategic partners. Daniel studied engineering with a double diploma from École Centrale de Paris, France, and University of Stuttgart, Germany. He received his Ph.D. in materials engineering at Cambridge University, UK.

Naman Demaghlatrous

Managing Director, Europe, Middle East & Africa

Mr. Demaghlatrous has more than 20 years of experience in the healthcare industry, including roles with medical device and pharmaceutical companies leading business strategy, international product licensing, business development and operations. He has proven expertise in leading organizations through start-up to rapid growth, expansion and value creation with companies such as Medtronic, Pediapharm, Johnson & Johnson and Atfal Pharma. Mr. Demaghlatrous will play an integral part in MedX’s revenue growth prospects by securing European, Middle Eastern and African partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in the Netherlands, Spain and Turkey, he will also be responsible for securing joint ventures and partnerships across the EMEA Region.

Chantal Ward, RN

Director, Dermatological Services

Chantal Ward RN, a Diploma Nurse Graduate from an operating room background, has 20+ years’ experience as a clinical trainer of advanced medical aesthetic equipment and technology. Her expertise is acknowledged across Canada and around the world, where she has provided guidance and training to hundreds of medical aesthetic professionals. Ms. Ward is Co-Founder of Clarity MedSpa & Laser Centre, Toronto and has significant experience with MedX’s SIAscopy on DermSecure™.

Anthony Milonas


Mr. Milonas is President and CEO of Canadian Orthodontic Partners, a company overseeing a national network of orthodontic practices. Mr. Milonas was responsible for the expansion of the group’s number of practices from 28 to approximately 55 and has held senior roles in both large publicly-traded companies as well as privately-held small and mid-sized companies. Mr. Milonas stated, “I am looking forward to working with such a talented team. MedX’s SIAscopy™ combined with its DermSecure™ platform are, in my view, an ideal combination for today’s challenging environment and the shift towards digital health care.”

Wayne Cockburn


Mr. Cockburn is President of The Clinic Network Canada, one of Canada’s largest providers of out-of-hospital pain management services. Mr. Cockburn previously founded the medical device company, iTech Medical, leading it through product approval in Europe and Canada. "I am very pleased to be joining the MedX team at such a pivotal time,” Mr. Cockburn said. “The meticulous development, regulatory and commercialization work that they've done over the past several years has, I believe, put them in a good position to not only become a leader in their field, but also allow them to save the lives of so many people who become affected by skin cancer."

Last changed at 21-Dec-2020 08:16AM